MUC1 and neoplasm: As MUC1 is a widely expressed tumor antigen, found on about 75% of tumors that kill, effective vaccine strategies with optimal peptides will have widespread applicability, especially as combined appropriately with immunomodulatory therapies such as checkpoint inhibitors.